| BioVision |
1785-500 |
EZSolution™ Gö 6976
|
500 µg |
|
|
| BioVision |
1782-50G |
Octyl-β-D-thioglucopyranoside
|
50 g |
|
|
| BioVision |
1782-5G |
Octyl-β-D-thioglucopyranoside
|
5 g |
|
|
| BioVision |
1782-1G |
Octyl-β-D-thioglucopyranoside
|
1 g |
|
|
| BioVision |
1780-5 |
PI3-Kɣ Inhibitor, AS-605240
|
5 mg |
|
|
| BioVision |
1780-1 |
PI3-Kɣ Inhibitor, AS-605240
|
1 mg |
|
|
| BioVision |
1777-5G |
Sulfobetaine 3-16
|
5 g |
|
|
| BioVision |
1777-25G |
Sulfobetaine 3-16
|
25 g |
|
|
| BioVision |
1778-1 |
Stat3 Peptide Inhibitor, Cell-Permeable
|
1 mg |
|
|
| BioVision |
1779-5 |
mTOR Inhibitor, Ku-0063794
|
5 mg |
|
|
| BioVision |
1779-1 |
mTOR Inhibitor, Ku-0063794
|
1 mg |
|
|
| BioVision |
1778-5 |
Stat3 Peptide Inhibitor, Cell-Permeable
|
5 mg |
|
|
| BioVision |
1775-25 |
Stat3 Inhibitor I, S3I-201
|
25 mg |
|
|
| BioVision |
1776-5 |
17-DMAG hydrochloride
|
5 mg |
|
|
| BioVision |
1773-250 |
Quercetin, Dihydrate
|
250 mg |
|
|
| BioVision |
1776-1 |
17-DMAG hydrochloride
|
1 mg |
|
|
| BioVision |
1775-5 |
Stat3 Inhibitor I, S3I-201
|
5 mg |
|
|
| BioVision |
1774-5 |
17-AAG
|
5 mg |
|
|
| BioVision |
1774-1 |
17-AAG
|
1 mg |
|
|
| BioVision |
1773-1000 |
Quercetin, Dihydrate
|
1 g |
|
|
| BioVision |
1772-250 |
Naringenin
|
250 mg |
|
|
| BioVision |
1772-1000 |
Naringenin
|
1 g |
|
|
| BioVision |
1770-1 |
D4476
|
1 mg |
|
|
| BioVision |
1770-5 |
D4476
|
5 mg |
|
|
| BioVision |
1768-1 |
H-89 Dihydrochloride
|
1 mg |
|
|
| BioVision |
1771-5 |
DR2313
|
5 mg |
|
|
| BioVision |
1771-1 |
DR2313
|
1 mg |
|
|
| BioVision |
1769-5 |
SB 216763
|
5 mg |
|
|
| BioVision |
1769-1 |
SB 216763
|
1 mg |
|
|
| BioVision |
1768-5 |
H-89 Dihydrochloride
|
5 mg |
|
|
| BioVision |
1765-100 |
Okadaic acid, Potassium Salt
|
100 µg |
|
|
| BioVision |
1767-5 |
PP2
|
5 mg |
|
|
| BioVision |
1767-1 |
PP2
|
1 mg |
|
|
| BioVision |
1766-100 |
Okadaic acid, Ammonium Salt
|
100 µg |
|
|
| BioVision |
1766-025 |
Okadaic acid, Ammonium Salt
|
25 µg |
|
|
| BioVision |
1763-10 |
Fludarabine Phosphate
|
10 mg |
|
|
| BioVision |
1765-025 |
Okadaic acid, Potassium Salt
|
25 µg |
|
|
| BioVision |
1764-100 |
Okadaic acid, Sodium Salt
|
100 µg |
|
|
| BioVision |
1764-025 |
Okadaic acid, Sodium Salt
|
25 µg |
|
|
| BioVision |
1763-50 |
Fludarabine Phosphate
|
50 mg |
|
|
| BioVision |
1762-10 |
Honokiol
|
10 mg |
|
|
| BioVision |
1761-1 |
Triptolide
|
1 mg |
|
|
| BioVision |
1762-50 |
Honokiol
|
50 mg |
|
|
| BioVision |
1760-10 |
Nafamostat Mesylate
|
10 mg |
|
|
| BioVision |
1761-5 |
Triptolide
|
5 mg |
|
|
| BioVision |
1759-25 |
Gemcitabine Hydrochloride
|
25 mg |
|
|
| BioVision |
1760-50 |
Nafamostat Mesylate
|
50 mg |
|
|
| BioVision |
1757-1G |
Sitagliptin Phosphate Monohydrate
|
1 g |
|
|
| BioVision |
1759-100 |
Gemcitabine Hydrochloride
|
100 mg |
|
|
| BioVision |
1758-500 |
Resveratrol
|
500 mg |
|
|